Patent details

EP1618879 Title: Injectable formulation of paclitaxel for cad treatment

Basic Information

Publication number:
EP1618879
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP052530466
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Injectable formulation of paclitaxel for cad treatment
French Title of Invention:
Formulation injectable de paclitaxel pour le traitement de la coronaropathie
German Title of Invention:
Injizierbare Formulierung von Paclitaxel zur KHK-Behandlung
SPC Number:

Dates

Filing date:
18/05/2005
Grant date:
27/02/2013
EP Publication Date:
27/02/2013
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/01/2006
EP B1 Publication Date:
27/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/05/2013
Expiration date:
18/05/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/05/2005
 
 

Name:
Cordis Corporation
Address:
14201 N.W. 60th Avenue, Miami Lakes, Florida 33014, United States (US)

Inventor

1

Name:
Falotico Robert
Address:
United States (US)

2

Name:
Zhao Jonathon Z.
Address:
United States (US)

Priority

Priority Number:
858954
Priority Date:
02/06/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/19;
Filing date Document type Number of pages